相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-KB signaling, and microglial activation
Mariana G. Fronza et al.
BRAIN BEHAVIOR AND IMMUNITY (2022)
1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4-carboxamide Reduces A beta Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease
Mariana G. Fronza et al.
NEUROCHEMICAL RESEARCH (2022)
Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer's Disease
Mariana G. Fronza et al.
ACS CHEMICAL NEUROSCIENCE (2021)
QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis
Mariana G. Fronza et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Depressive Symptoms in the Elderly-An Early Symptom of Dementia? A Systematic Review
Wietse Wiels et al.
FRONTIERS IN PHARMACOLOGY (2020)
Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease
Thomas Berger et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission
Tugce Munise Satir et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Depression screening in cognitively normal older adults: Measurement bias according to subjective memory decline, brain amyloid burden, cognitive function, and sex
Louisa Thompson et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)
Monoaminergic System Modulation in Depression and Alzheimer's Disease: A New Standpoint?
Maria Grazia Morgese et al.
FRONTIERS IN PHARMACOLOGY (2019)
Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer's disease
Mariana G. Fronza et al.
SCIENTIFIC REPORTS (2019)
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice
Ramona Belfiore et al.
AGING CELL (2019)
Diagnosing and Treating Depression in Patients with Alzheimer's Disease
Anna D. Burke et al.
NEUROLOGY AND THERAPY (2019)
Impaired AMPA signaling and cytoskeletal alterations induce early synaptic dysfunction in a mouse model of Alzheimer's disease
David Baglietto-Vargas et al.
AGING CELL (2018)
Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults
Nancy J. Donovan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Data-driven models of dominantly-inherited Alzheimer's disease progression
Neil P. Oxtoby et al.
BRAIN (2018)
Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress
Kanchan Bisht et al.
NEUROBIOLOGY OF STRESS (2018)
Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study
Jennifer R. Gatchel et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Role of ADAM10 in Alzheimer's Disease
Xiang-Zhen Yuan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management
Larry Culpepper et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Late-Life Depression and the Prodromes of Dementia
David Carl Steffens
JAMA PSYCHIATRY (2017)
Depression as a modifiable factor to decrease the risk of dementia
O. P. Almeida et al.
TRANSLATIONAL PSYCHIATRY (2017)
Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study
Peng Li et al.
EJNMMI RESEARCH (2017)
Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease
Lulin Nie et al.
BIOFACTORS (2017)
Impaired retention of depression-like behavior in a mouse model of Alzheimer's disease
Xianwen Luo et al.
IBRO REPORTS (2017)
12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice
Antonio Di Meco et al.
BIOLOGICAL PSYCHIATRY (2017)
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels
Ganesh M. Babulal et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)
Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model
Jiqing Xu et al.
SCIENTIFIC REPORTS (2016)
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease
Robert J. Baranello et al.
CURRENT ALZHEIMER RESEARCH (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Brain derived neurotrophic factor is involved in the regulation of glycogen synthase kinase 3β (GSK3β) signalling
Vivek Gupta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Parallels Between Major Depressive Disorder and Alzheimer's Disease: Role of Oxidative Stress and Genetic Vulnerability
Roberto Rodrigues et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions
Michael Klingener et al.
JOURNAL OF NEUROSCIENCE (2014)
GSK3b, But Not GSK3a, Inhibits the Neuronal Differentiation of Neural Progenitor Cells As a Downstream Target of Mammalian Target of Rapamycin Complex1
Jyhyun Ahn et al.
STEM CELLS AND DEVELOPMENT (2014)
Elevated CSF Tau is Associated With Psychosis in Alzheimer's Disease
Jeremy Koppel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Dual effects of increased glycogen synthase kinase-3β activity on adult neurogenesis
Almudena Fuster-Matanzo et al.
HUMAN MOLECULAR GENETICS (2013)
Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
J. H. Ledo et al.
MOLECULAR PSYCHIATRY (2013)
ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function
Jaehong Suh et al.
NEURON (2013)
Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions
Masashi Kitazawa et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-Harbi
PATIENT PREFERENCE AND ADHERENCE (2012)
Depression in dementia: epidemiology, mechanisms, and treatment
Daniela Enache et al.
CURRENT OPINION IN PSYCHIATRY (2011)
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 2. Behavioral and cognitive changes
Roxanne Sterniczuk et al.
BRAIN RESEARCH (2010)
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
Jacqueline Blundell et al.
JOURNAL OF NEUROSCIENCE (2010)
ADAM-10 over-expression increases cortical synaptogenesis
Karen F. S. Bell et al.
NEUROBIOLOGY OF AGING (2008)
Inflammation, depression and dementia: Are they connected?
Brian E. Leonard
NEUROCHEMICAL RESEARCH (2007)
Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM)
C. Leann Hinkle et al.
JOURNAL OF NEUROBIOLOGY (2006)
Depression and risk for Alzheimer disease - Systematic review, meta-analysis, and metaregression analysis
RL Ownby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression
MA Rapp et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Depression as a risk factor for Alzheimer disease - The MIRAGE study
RC Green et al.
ARCHIVES OF NEUROLOGY (2003)
BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents
L Mai et al.
JOURNAL OF NEUROCHEMISTRY (2002)
分享论文
